Takoma Regional Hospital INC
Takoma Regional Hospital INC was paid $20.22M by Medicaid between Jan 2018 and Dec 2024, across 219 billing codes. Its largest line is 99284, emergency room visit (serious) — 28% of everything it billed.
GREENEVILLE, TN 37745
Next to other Family Medicine Physician providers in Tennessee
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 104,335 | $2.23M | |
| 2019 | 111,918 | $2.58M | |
| 2020 | 91,888 | $2.51M | |
| 2021 | 104,980 | $3.18M | |
| 2022 | 126,358 | $3.51M | |
| 2023 | 131,725 | $3.26M | |
| 2024incomplete | 104,580 | $2.95M |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 28% | 30,246 | 26,886 | $5.69M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 14% | 80,924 | 58,656 | $2.79M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 13% | 12,918 | 10,745 | $2.66M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 11% | 16,439 | 15,044 | $2.21M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 5.6% | 45,186 | 34,670 | $1.14M |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 3.8% | 8,508 | 7,686 | $770K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 3.6% | 5,312 | 2,429 | $736K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | 2.3% | 3,467 | 1,514 | $467K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 1.9% | 9,666 | 3,019 | $385K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 1.8% | 49,400 | 39,032 | $361K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1.4% | 3,919 | 3,608 | $279K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 1.2% | 6,897 | 2,143 | $242K |
207 more codes
| 99203 | Doctor's office visit, new patient (routine) | 1.0% | 4,647 | $212K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 46,877 | $148K |
| 59400 | Routine obstetric care including antepartum care, vaginal delivery, and postpartum care | <1% | 103 | $122K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 13,079 | $108K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 7,626 | $93K |
| 80053 | Comprehensive metabolic panel | <1% | 41,781 | $85K |
| 36415 | Collection of venous blood by venipuncture | <1% | 68,190 | $74K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 1,395 | $70K |
| 43235 | <1% | 680 | $70K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 11,610 | $68K |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 751 | $65K |
| G0378 | Hospital observation service, per hour | <1% | 719 | $64K |
| 99401 | <1% | 2,929 | $63K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 932 | $63K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 971 | $61K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 914 | $55K |
| 84484 | <1% | 9,119 | $55K | |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | <1% | 305 | $46K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 1,421 | $46K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 1,092 | $44K |
| 97597 | <1% | 1,608 | $37K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 5,857 | $34K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 9,681 | $31K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 1,789 | $31K |
| 80061 | Lipid panel | <1% | 10,625 | $29K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 10,970 | $27K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 555 | $26K |
| 99443 | <1% | 1,736 | $22K | |
| 81025 | <1% | 5,866 | $22K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 6,218 | $22K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 1,503 | $22K |
| 90837 | Psychotherapy session, about an hour | <1% | 231 | $20K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 5,988 | $20K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 1,759 | $19K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 1,759 | $19K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 4,295 | $19K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 564 | $18K |
| 99442 | <1% | 1,810 | $18K | |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 264 | $17K |
| 90686 | <1% | 1,818 | $17K | |
| J7307 | Etonogestrel (contraceptive) implant system, including implant and supplies | <1% | 15 | $15K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 3,031 | $15K |
| 83690 | <1% | 5,277 | $15K | |
| 80305 | <1% | 1,739 | $15K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 406 | $13K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 351 | $12K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 8,742 | $12K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 331 | $11K |
| 71045 | Radiologic examination, chest; single view | <1% | 7,709 | $11K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 1,264 | $11K |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | <1% | 763 | $10K |
| 91200 | <1% | 1,104 | $10K | |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 186 | $10K |
| 76801 | <1% | 143 | $9K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 205 | $9K |
| 87081 | <1% | 3,439 | $8K | |
| 81001 | <1% | 14,381 | $8K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,877 | $8K |
| 43248 | <1% | 166 | $8K | |
| 90715 | <1% | 207 | $8K | |
| 84703 | <1% | 1,847 | $8K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 3,144 | $7K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 364 | $7K |
| 83880 | <1% | 1,705 | $7K | |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | <1% | 2,125 | $7K |
| 99205 | Prolong outpt/office vis | <1% | 384 | $7K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 1,645 | $6K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 251 | $6K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 150 | $6K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 861 | $6K |
| 80055 | <1% | 389 | $6K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 430 | $5K |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | <1% | 662 | $5K |
| 84439 | <1% | 3,761 | $5K | |
| 87653 | <1% | 262 | $5K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 389 | $5K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 2,502 | $4K |
| 86803 | <1% | 831 | $4K | |
| 11721 | <1% | 833 | $4K | |
| 81003 | <1% | 7,800 | $4K | |
| 82607 | <1% | 1,357 | $4K | |
| 90833 | Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) | <1% | 278 | $4K |
| 82652 | <1% | 470 | $3K | |
| 76830 | Ultrasound, transvaginal | <1% | 63 | $3K |
| 87040 | <1% | 882 | $3K | |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 60 | $3K |
| 82043 | <1% | 888 | $3K | |
| 99441 | <1% | 316 | $3K | |
| 74018 | <1% | 114 | $3K | |
| 99221 | <1% | 96 | $2K | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 443 | $2K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 34 | $2K |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 519 | $2K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 102 | $2K |
| 82570 | <1% | 893 | $2K | |
| 83735 | <1% | 899 | $2K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 122 | $2K |
| 99490 | Ccm add 20min | <1% | 730 | $1K |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 508 | $1K |
| 83605 | <1% | 415 | $1K | |
| 87015 | <1% | 262 | $1K | |
| G0475 | Hiv antigen/antibody, combination assay, screening | <1% | 148 | $1K |
| 90677 | <1% | 41 | $1K | |
| 11981 | <1% | 14 | $1K | |
| 99406 | <1% | 260 | $1K | |
| 99223 | Prolong inpt eval add15 m | <1% | 31 | $1K |
| 82950 | <1% | 255 | $1K | |
| 3074F | <1% | 27,160 | $1K | |
| 85610 | <1% | 699 | $1K | |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 18 | $1K |
| 3078F | <1% | 25,462 | $1K | |
| J1650 | Injection, enoxaparin sodium, 10 mg | <1% | 19 | $1K |
| 85379 | <1% | 199 | $968.48 | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 13 | $817.11 |
| 80076 | <1% | 466 | $784.84 | |
| 59025 | Fetal non-stress test | <1% | 15 | $748.00 |
| 85027 | <1% | 423 | $707.95 | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 108 | $701.28 |
| 86900 | <1% | 57 | $670.22 | |
| 87420 | <1% | 93 | $659.01 | |
| 90791 | Psychiatric diagnostic evaluation | <1% | 12 | $620.92 |
| 94690 | <1% | 40 | $603.92 | |
| 86850 | <1% | 57 | $581.55 | |
| U0001 | Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel | <1% | 23 | $574.59 |
| 93018 | <1% | 61 | $555.74 | |
| 3079F | <1% | 2,486 | $550.19 | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 1,741 | $520.90 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 129 | $489.27 |
| 84436 | <1% | 370 | $441.30 | |
| 73562 | <1% | 53 | $441.12 | |
| 92250 | <1% | 17 | $420.29 | |
| 73630 | <1% | 61 | $388.71 | |
| 93016 | <1% | 41 | $375.49 | |
| 99307 | <1% | 23 | $361.75 | |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 54 | $358.63 |
| 84480 | <1% | 102 | $302.32 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 2,838 | $282.90 |
| 86592 | <1% | 222 | $282.90 | |
| 3077F | <1% | 2,053 | $250.00 | |
| 86901 | <1% | 57 | $232.09 | |
| 82150 | <1% | 103 | $228.78 | |
| 3075F | <1% | 2,684 | $222.57 | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 2,691 | $190.59 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 6,224 | $185.01 |
| 90662 | <1% | 174 | $170.42 | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 13 | $160.41 |
| J2920 | Injection, methylprednisolone sodium succinate, up to 40 mg | <1% | 54 | $140.88 |
| 84550 | <1% | 146 | $139.62 | |
| 87340 | <1% | 108 | $136.47 | |
| 0358T | <1% | 56 | $130.85 | |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and allowed practitioners to affirm the initial implementation of the plan of care | <1% | 31 | $121.97 |
| 87510 | <1% | 44 | $107.81 | |
| 87480 | <1% | 44 | $107.80 | |
| 87660 | <1% | 44 | $105.85 | |
| 87807 | <1% | 12 | $104.08 | |
| 86141 | <1% | 20 | $87.24 | |
| G0444 | Annual depression screening, 5 to 15 minutes | <1% | 221 | $85.40 |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 404 | $79.22 |
| 86140 | <1% | 44 | $77.49 | |
| 84153 | <1% | 69 | $77.35 | |
| 86762 | <1% | 56 | $73.40 | |
| G0008 | Administration of influenza virus vaccine | <1% | 1,075 | $68.96 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 235 | $66.24 |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 6,671 | $60.74 |
| 84100 | <1% | 59 | $58.87 | |
| 85730 | <1% | 17 | $47.12 | |
| 84154 | <1% | 25 | $46.90 | |
| 85652 | <1% | 13 | $42.78 | |
| 87077 | <1% | 533 | $40.40 | |
| 82397 | <1% | 15 | $40.26 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 16 | $38.55 |
| 96160 | <1% | 405 | $36.23 | |
| 96127 | <1% | 42 | $35.91 | |
| 87205 | <1% | 35 | $35.08 | |
| 81002 | <1% | 12 | $33.14 | |
| J2272 | Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg | <1% | 32 | $27.15 |
| 83525 | <1% | 15 | $23.32 | |
| 90653 | <1% | 26 | $21.06 | |
| 3080F | <1% | 294 | $20.00 | |
| G0127 | Trimming of dystrophic nails, any number | <1% | 16 | $17.68 |
| 94664 | <1% | 46 | $16.28 | |
| 82746 | <1% | 40 | $15.00 | |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | <1% | 28 | $12.24 |
| 0502F | <1% | 16,196 | $10.00 | |
| 3044F | <1% | 755 | $10.00 | |
| 84481 | <1% | 16 | $8.64 | |
| 85007 | <1% | 29 | $5.25 | |
| 87075 | <1% | 19 | $4.82 | |
| 87186 | <1% | 44 | $4.41 | |
| 87070 | <1% | 19 | $4.39 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | 0% | 1,678 | $0.00 |
| 99397 | 0% | 44 | $0.00 | |
| 4010F | 0% | 6,989 | $0.00 | |
| J7042 | 5% dextrose/normal saline (500 ml = 1 unit) | 0% | 15 | $0.00 |
| 0503F | 0% | 752 | $0.00 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 0% | 801 | $0.00 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 0% | 74 | $0.00 |
| J2704 | Injection, propofol, 10 mg | 0% | 3,797 | $0.00 |
| J0690 | Injection, cefazolin sodium, 500 mg | 0% | 350 | $0.00 |
| A9270 | Non-covered item or service | 0% | 761 | $0.00 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 0% | 264 | $0.00 |
| 0500F | 0% | 169 | $0.00 | |
| C1769 | Guide wire | 0% | 46 | $0.00 |
| G0009 | Administration of pneumococcal vaccine | 0% | 33 | $0.00 |
| J1170 | Injection, hydromorphone, up to 4 mg | 0% | 20 | $0.00 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 0% | 17 | $0.00 |
| 94760 | 0% | 42 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.